The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
it's in the NAD synthesis pathway correct that's exactly right it's in the NAD pathway NAD is one of the oxidative stress regulators and energy Regulators of our cells so it's a very critical molec in the metabolism of our cells and there was very strong evidence in preclinical models of mice given glaucoma that manipulating this pathway and and sort of increasing this pathway could be protective in glaucoma or other optic neuropathies optic nerve degenerative diseases
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.